Human rheumatoid factor production is dependent on CD40 signaling and autoantigen

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3116-3122

  Kyburz, Diego ^a   Corr, Maripat ^a   Brinson, Diana C ^a   Von Damm, Amila ^a   Tighe, Helen ^a   Carson, Dennis A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD40 ANTIGEN; RHEUMATOID FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD40; AUTOANTIGENS; B-LYMPHOCYTES; CD40 LIGAND; CELL SURVIVAL; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; INTERLEUKIN-15; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE TRANSFUSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RHEUMATOID FACTOR; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033567958     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Mageed, R. A., M. Borretzen, S. P. Moyes, K. M. Thompson, and J. B. Natvig. 1997. Rheumatoid factor autoantibodies in health and disease. Ann. NY Acad. Sci. 815:296.
2. Tighe, H., and D. A. Carson. 1997. Rheumatoid factors. In Textbook of Rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, eds. Saunders, Philadelphia, PA, p. 241.
3. Nemazee, D. A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
4. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
5. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331.
6. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765.
7. Wang, H., and M. J. Shlomchik. 1997. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159:1125.
8. Goodnow, C. C., J. Crosbie, H. Jorgensen, R. A. Brink, and A. Basten. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342:385.
9. Russell, D. M., Z. Dembic, G. Morahan, J. F. Miller, K. Burki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature 354:308.
10. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77.
11. Olee, T., E. W. Lu, D. F. Huang, R. W. Soto-Gil, M. Deftos, F. Kozin, D. A. Carson, and P. P. Chen. 1992. Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response. J. Exp. Med. 175:831.
12. Youngblood, K., L. Fruchter, G. Ding, J. Lopez, V. Bonagura, and A. Davidson. 1994. Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated. J. Clin. Invest. 93:852.
13. Randen, I., V. Pascual, K. Victor, K. M. Thompson, O. Forre, J. D. Capra, and J. B. Natvig. 1993. Synovial IgG rheumatoid factors show evidence of an antigendriven immune response and a shift in the V gene repertoire compared to IgM rheumatoid factors. Eur. J. Immunol. 23:1220.
14. Borretzen, M., C. Chapman, J. B. Natvig, and K. M. Thompson. 1997. Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage. Eur. J. Immunol. 27:735.
15. Tighe, H., P. Heaphy, S. Baird, W. O. Weigle, and D. A. Carson. 1995. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J. Exp. Med. 181:599.
16. Warnatz, K., D. Kyburz, D. C. Brinson, D. J. Lee, A. Von Damm, M. Engelhart, M. Corr, D. A. Carson, and H. Tighe. 1999. Rheumatoid factor B cell tolerance via autonomous Fas/FasL-independent apoptosis. Cell. Immunol. 191:69.
17. Tighe, H., K. Warnatz, D. Brinson, M. Corr, W. O. Weigle, S. M. Baird, and D. A. Carson. 1997. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc. Natl. Acad. Sci. USA 94:646.
18. Mayumi, M., S. Sumimoto, S. Kanazashi, D. Hata, K. Yamaoka, Y. Higaki, T. Ishigami, K. M. Kim, T. Heike, and K. Katamura. 1996. Negative signaling in B cells by surface immunoglobulins. J. Allergy Clin. Immunol. 98:S238.
19. Hasbold, J., and G. G. Klaus. 1990. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20:1685.
20. Benhamou, L. E., P. A. Cazenave, and P. Sarthou. 1990. Anti-immunoglobulins induce death by apoplosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20:1405.
21. Boyd, A. W., and J. W. Schrader. 1981. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J. Immunol. 126:2466.
22. Ishigami, T., K. M. Kim, Y. Horiguchi, Y. Higaki, D. Hata, T. Heike, K. Katamura, M. Mayumi, and H. Mikawa. 1992. Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J. Immunol. 148:360.
23. Pennell, C. A., and D. W. Scott. 1986. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur. J. Immunol. 16:1577.
24. Sumimoto, S., T. Heike, S. Kanazashi, N. Shintaku, E. Y. Jung, D. Hata, K. Katamura, and M. Mayumi. 1994. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J. Immunol. 153: 2488.
25. Valentine, M. A., and K. A. Licciardi. 1992. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur. J. Immunol. 22:3141.
26. Parry, S. L., J. Hasbold, M. Holman, and G. G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152:2821.
27. Finkelman, F. D., J. M. Holmes, O. I. Dukhanina, and S. C. Morris. 1995. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181:515.
28. Tsubata, T., J. Wu, and T. Honjo. 1993. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364: 645.
29. Parry, S. L., M. J. Holman, J. Hasbold, and G. G. Klaus. 1994. Plastic-immobilized anti-μ or anti-δ antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24:974.
30. Illera, V. A., C. E. Perandones, L. L. Stunz, D. A. Mower, Jr., and R. F. Ashman. 1993. Apoptosis in splenic B lymphocytes: regulation by protein kinase C and IL-4. J. Immunol. 151:2965.
31. Ridderstad, A., M. Abedi-Valugerdi, and E. Moller. 1991. Cytokines in rheumatoid arthritis. Ann. Med. 23:219.
32. Shimaoka, Y., J. F. Attrep, T. Hirano, K. Ishihara, R. Suzuki, T. Toyosaki, T. Ochi, and P. E. Lipsky. 1998. Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J. Clin. Invest. 102:606.
33. MacDonald, K. P., Y. Nishioka, P. E. Lipsky, and R. Thomas. 1997. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J. Clin. Invest. 100: 2404.
34. Mach, F., U. Schonbeck, G. K. Sukhova, T. Bourcier, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94:1931.
35. Henn, V., J. R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus, and R. A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591.
36. Tighe, H., P. P. Chen, R. Tucker, T. J. Kipps, J. Roudier, F. R. Jirik, and D. A. Carson. 1993. Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J. Exp. Med. 177:109.
37. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. L. Vayssiere, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
38. Gleichmann, E., E. H. Van Elven, and J. P. Van der Veen. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12:152.
39. Morris, S. C., R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171:503.
40. McInnes, I. B., J. al-Mughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175.
41. McInnes, I. B., B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 3:189.
42. Thurkow, E. W., I. M. van der Heijden, F. C. Breedveld, T. J. Smeets, M. R. Daha, P. M. Kluin, A. E. Meinders, and P. P. Tak. 1997. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 181: 444.
43. Isomaki, P., R. Luukkainen, P. Toivanen, and J. Punnonen. 1996. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 39:1693.
44. Tominaga, Y., M. Nagata, H. Yasuda, N. Okamoto, K. Arisawa, H. Moriyama, M. Miki, K. Yokono, and M. Kasuga. 1998. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86:209.
45. Inobe, J. I., Y. Chen, and H. L. Weiner. 1996. In vivo administration of IL-4 induces TGF-β-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 778:390.
46. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:705.
47. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209.
48. Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. Macduff, T. A. Sato, C. R. Maliszewski, and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543.
49. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091.
50. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
51. Splawski, J. B., S. M. Fu, and P. E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276.
52. Fulcher, D. A., A. B. Lyons, S. L. Korn, M. C. Cook, C. Koleda, C. Parish, B. Fazekas de St. Groth, and A. Basten. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183:2313.
53. Ens, J. M., A. Basten, R. Brink, K. Doherty, M. R. Kehry, and P. D. Hodgkin. 1994. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc. Natl. Acad. Sci. USA 91:4392.
54. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.
55. Grammer, A. C., M. C. Bergman, Y. Miura, K. Fujita, L. S. Davis, and P. E. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:4996.
56. Schattner, E. J., J. Mascarenhas, I. Reyfman, M. Koshy, C. Woo, S. M. Friedman, and M. K. Crow. 1998. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91:2689.
57. Devi, B. S., S. Van Noordin, T. Krausz, and K. A. Davies. 1998. Peripheral blood lymphocytes in SLE - hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J. Autoimmun. 11:471.
58. Dechanet, J., P. Merville, I. Durand, J. Banchereau, and P. Miossec. 1995. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J. Clin. Invest. 95: 456.
59. Reparon-Schuijt, C. C., W. J. van Esch, C. van Kooten, E. W. Levarht, F. C. Breedveld, and C. L. Verweij. 1998. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum. 41:2211.
60. Mohan, C., S. Yan, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.